37 269

Cited 5 times in

Antiplatelet activity of BRX-018, (6aS,cis)-malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester.

Authors
Lee, GY; Chang, TS; Lee, KS; Khil, LY; Kim, D; Chung, JH; Kim, YC; Lee, BH; Moon, CH; Moon, CK
Citation
Thrombosis research, 115(4):309-318, 2005
Journal Title
Thrombosis research
ISSN
0049-38481879-2472
Abstract
Brazilin (7,11b-dihydrobenz[b]indeno[1,2-d]pyran-3,6a,9,10 (6H)-tetrol), the major component of Caesalpinia sappan L., was reported to show antiplatelet activity through the inhibition of phospholipase A2 (PLA2) activity and the increase in intracellular free Ca2+ concentration ([Ca2+]i). To search more potential antiplatelet agent, brazilin derivatives were synthesized and examined for their effects on the platelet aggregation. Among those compounds, BRX-018, (6aS,cis)-Malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester, was confirmed as one of the potential antiplatelet agents. In the present study, we investigated the antiplatelet mechanism of BRX-018. BRX-018 inhibited the thrombin-, collagen-, and ADP-induced rat platelet aggregation in a concentration-dependent manner, with IC50 values of 35, 15, and 25 microM, respectively. BRX-018 also inhibited thrombin-induced dense granule secretion, thromboxane A2 (TXA2) synthesis, and [Ca2+]i elevation in platelets. BRX-018 was also found to inhibit A23187-induced [Ca2+]i and aggregation in the presence of apyrase (ADP scavenger) but not in the presence of both apyrase and indomethacin (a specific inhibitor of cyclooxygenase, COX). Although BRX-018 significantly inhibited arachidonic acid (AA)-induced aggregation and TXA2 synthesis, it had no significant inhibitory effect on cyclooxygenase activity in vitro. In contrast, BRX-018 inhibited the activity of purified PLA2. Dixon plot showed that this inhibition was mixed type with an inhibition constant of Ki=23 microM. Taken together, the present study suggests that BRX-018 may be a promising antiplatelet agent and that its antiplatelet activity may be based on the inhibitory mechanisms on TXA2 synthesis in stimulated platelets.
MeSH terms
Adenosine Diphosphate/pharmacologyAnimalsArachidonic Acid/pharmacologyBenzopyrans/chemical synthesisBenzopyrans/chemistryBenzopyrans/pharmacology*Blood Platelets/drug effectsBlood Platelets/physiologyCalcimycin/pharmacologyCalcium/bloodCattleCell Degranulation/drug effectsCollagen/pharmacologyIonophores/pharmacologyMaleMalonates/chemical synthesisMalonates/chemistryMalonates/pharmacology*Phospholipases A/antagonists & inhibitorsPhospholipases A2Platelet Aggregation Inhibitors/chemical synthesisPlatelet Aggregation Inhibitors/chemistryPlatelet Aggregation Inhibitors/pharmacology*Prostaglandin-Endoperoxide Synthases/bloodRatsRats, Sprague-DawleySwineThrombin/pharmacologyThromboxane B2/blood
DOI
10.1016/j.thromres.2004.09.018
PMID
15668191
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Physiology
AJOU Authors
문, 창현
Full Text Link
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse